Posted On: November 6, 2009

New Safety Warnings About Diabetes Drug and Kidney Functions

Recently, the safety warnings were strengthened for the diabetes drug Byetta relating to the risks of pancreatitis and the medicine’s use by patients with severe kidney disease. Specifically, the US Food and Drug Administration ("FDA") notified healthcare professionals of revisions to the prescribing information for Byetta (exenatide) to include information on post-marketing reports of altered kidney function, including acute renal failure and insufficiency.

Continue reading " New Safety Warnings About Diabetes Drug and Kidney Functions " »

Bookmark and Share